微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 41.31% | 5.17% | 3.05% | 88/139 | 51.97% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-12-31 | 40.09% | -4.72% | 1.9% | 92/139 | 51.43% | 佰仁医疗 | 89.18% | 行业排名> |
| 2025-09-30 | 39.34% | -5.84% | 4.86% | 91/139 | 51.66% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-06-30 | 37.52% | -8.56% | -4.49% | 96/139 | 51.8% | 佰仁医疗 | 88.54% | 行业排名> |
| 2025-03-31 | 39.28% | 2.6% | -6.65% | 90/139 | 51.48% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 42.08% | 2.15% | 0.7% | 90/139 | 52.35% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 41.78% | -2.51% | 1.84% | 90/139 | 53.23% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 41.03% | -6.71% | 7.17% | 92/139 | 53.35% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 38.29% | -11.77% | -7.05% | 92/139 | 53.36% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 41.19% | -4.3% | -3.89% | 96/139 | 53.18% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 42.86% | -0.25% | -2.56% | 87/139 | 54.03% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 43.98% | 5.86% | 1.36% | 88/139 | 53.47% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 43.39% | 2% | 0.81% | 86/139 | 53.71% | 正海生物 | 89.78% | 行业排名> |
| 2022-12-31 | 43.04% | -4.15% | 0.18% | 91/139 | 53.71% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 42.97% | 2% | 3.41% | 84/139 | 55.18% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 41.55% | -6.71% | -7.47% | 93/139 | 54.84% | 三友医疗 | 90.29% | 行业排名> |
| 2021-12-31 | 44.91% | -10.18% | 0.83% | 93/139 | 57.28% | 三友医疗 | 90.73% | 行业排名> |
| 2021-06-30 | 44.54% | 2% | -10.92% | 90/139 | 58.4% | 三友医疗 | 90.5% | 行业排名> |
| 2020-12-31 | 49.99% | 2.38% | 2.38% | 87/139 | 59.49% | 三友医疗 | 90.29% | 行业排名> |
| 2019-12-31 | 48.83% | 9.13% | 9.13% | 74/139 | 56.29% | 正海生物 | 90.78% | 行业排名> |
| 2018-12-31 | 44.74% | 2% | 2% | 71/139 | 55.53% | 正海生物 | 91.59% | 行业排名> |